Table 1 Clinical and laboratory characteristics of 96 patients at ALL onset.

Initial diagnosis age, years,mean (range)

6.78 (1.5–15)

Sex, N (%)

 Male

63 (65.6)

 Female

33 (34.4)

BMI, SDS, mean (SDS)

− 0.73 (− 5.98 to 2.09)

WBC 10⁹ /L, mean (range)

59.82 (0.78–480.10)

Haemoglobin g/L, mean (range)

83.05 (31.40–136.00)

PLT 10⁹/L, mean (range)

100.60 (5.00–961.00)

ALC 10⁹/L, mean (range)

33.51 (0.38–243.40)

CRP mg/L,mean (range)

24.63 (0.50–145.04)

ALB g/L, mean (range)

39.64 (28.60–48.30)

Prealbumin mg/L,mean (range)

145.74 (59.70–335.50)

LDH U/Lmean (range)

929.38 (152.00–4347.00)

Uric acid umol/L, mean (range)

425.03 (105.00–2678.00)

Somatotype N (%)

 Normal weight

81 (84.38)

 Underweight

10 (10.42)

 Overweight

5 (5.21)

Immunophenotype N (%)

 B-lineage

79 (82.30)

 T-lineage

17 (17.70)

Risk stratification N (%)

 Low risk

22 (22.90)

 Intermediate risk

36 (37.50)

 High risk

38 (39.60)

Outcome number N (%)

 Complete remission

82 (85.40)

 Relapse

7 (7.30)

 Deceased

7 (7.30)

Hospital stay, day, mean (range)

31 (22.25–33)